Speaker illustration

Doctor David Corcoran

Queen Elizabeth University Hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)

A randomised, placebo-controlled trial of the effects of IV serelaxin on myocardial blood flow and vascular function in patients with stable coronary artery disease (CAD).

Event: ESC Congress 2017

Topic: Heart failure, other

Session: Acute Heart Failure (AHF)


A randomised controlled trial of the effect of remote ischaemic pre-conditioning on coronary endothelial function in patients with angina (RIC-COR).

Event: ESC Congress 2017

Topic: Angina pectoris stable

Session: Stable CAD


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb